Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A(BRKRP)

Research Snapshot

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) is a Healthcare stock with a market cap of $5.79B. The stock last traded around $445.10 and up 64.6% across the available one-year price window (Sep 4, 2025 → Jun 23, 2026). Baseline metrics include revenue growth of +2.1%, EPS growth of -119.7%, a dividend yield of 0.5%. What stands out right now is revenue +2.1%, EPS -119.7%, free cash flow -68.2% with operating margin 5.4% and ROIC -1.5%. The dividend is present but secondary, with a yield around 0.5%. Valuation is more restrained than many high-expectation growth names at price/sales 1.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines BRKRP price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.